The 9-valent HPV vaccine protects against HPV types 16 and 18, which cause about 66% of cervical cancers and most other HPV-attributable cancers in the United States, and five …

What is GARDASIL ® 9 (Human Papillomavirus 9-valent Vaccine, Recombinant)? GARDASIL 9 helps protect individuals ages 9 to 45 against the following diseases caused by 9 types of …

Gardasil 9 vaccine prevents diseases caused only by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. It will not prevent diseases caused by other types of HPV. The Centers for Disease Control …

During clinical trials before the licensure, the 9-valent HPV vaccine Gardasil 9 was studied in more than 15,000 males and females and was found to be safe and effective. For more …

Aug 20, 2024 · In the past, the quadrivalent HPV vaccine (Gardasil, 4vHPV) and bivalent HPV vaccine (Cervarix, 2vHPV) were licensed by the U.S. Food and Drug Administration (FDA). All …

GARDASIL 9 is a vaccine indicated in females 9 through 45 years of age for the prevention of cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers caused by …

Aug 25, 2023 · The HPV vaccine protects against genital warts and most cases of cervical cancer. It protects against cancer of the vagina, vulva, penis or anus caused by HPV. The …

Mar 15, 2024 · Product approval information for Human Papillomavirus 9-valent Vaccine, Recombinant also known as Gardasil 9.

Gardasil is a vaccine to prevent HPV, that, for maximum effect, is recommended for individuals prior to them becoming sexually active. [23] Moreover, evidence supports the conclusion that …

GARDASIL® is a vaccine indicated in girls and women 9 through26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in …